Ernexa Therapeutics Inc. (ERNA, ERNAW)

CIK 748592 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ernexa Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Sep 1, 202640001493152-26-041133
Sep 1, 202640001493152-26-041135
Sep 1, 202640001493152-26-041137
Sep 1, 202640001493152-26-041130
Sep 1, 202640001493152-26-041132
Sep 1, 202640001493152-26-041131
Aug 27, 202630001493152-26-040466
Aug 6, 202610-Q0001493152-26-036424
Jul 2, 20268-K0001493152-26-031920
Jul 2, 20268-K0001493152-26-031930
Jun 26, 20268-K0001493152-26-030306
May 20, 2026SCHEDULE 13G/A0001708828-26-000225
May 15, 2026SCHEDULE 13G/A0001193125-26-227556
May 15, 2026SCHEDULE 13G/A0001193125-26-227548
May 14, 2026SCHEDULE 13G0001171520-26-000096
May 14, 2026SCHEDULE 13G0001708828-26-000185
May 13, 2026SCHEDULE 13G/A0001104659-26-060524
May 11, 2026ARS0001493152-26-022288
May 11, 202610-Q0001493152-26-022276
May 11, 2026DEF 14A0001493152-26-022281
May 11, 2026DEFA14A0001493152-26-022284
May 4, 20268-K0001493152-26-021112
Apr 13, 2026DEF 14C0001493152-26-016310
Apr 1, 2026PRE 14C0001493152-26-014709
Mar 30, 2026EFFECT9999999995-26-000994